T
LIVE

Serial Number

79386129

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Nov 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

T Trademark

Serial Number: 79386129 • Registration: 7772609

T is a trademark filed by Telix Pharmaceuticals Limited on November 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

November 14, 2023

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Downloadable computer operating software; Downloadable computer application software for mobile phones, portable media players, and handheld computers, namely, software for the treatment, prevention, or diagnosis of cancer; Software as a Medical Device (SaMD), downloadable, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for medical purposes, namely, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for the treatment, prevention, or diagnosis of cancer

Medical analysis services for the diagnosis and treatment of persons with cancer; medical analysis services relating to the treatment of persons; medical diagnostic services; medical health assessment services; services for the preparation of medical reports, namely, providing medical information to patients, in the form of reports in the field of cancer; advisory services relating to medical services; consultancy and advisory services in relation to medical services; provision of medical information; Consulting services in the field of healthcare; health screening services in the field of cancer; providing information relating to health care services; preparation of reports relating to health care matters for medical purposes

Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; medical apparatus for use in laparoscopy; Medical apparatus for detecting cancer; Surgical instruments and apparatus; detecting instruments for medical use for detecting cancer; Medical instruments for use in the treatment, prevention, or diagnosis of cancer; Test equipment for medical use, namely, medical diagnostic instrument for cancer; diagnostic imaging apparatus for medical use; medical imaging apparatus; Probes for medical purposes; surgical instruments in the nature of surgical probes; surgical robots; nanorobots for medical purposes for surgical use

Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; Contrast media for use with medical equipment; Diagnostic agents for medical use in in vivo scanning; Compositions for medical use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, cancer; Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer

Software as a service (SAAS) services featuring software for the treatment, prevention, or diagnosis of cancer; computer software design; computer software development; computer software programming services for others in the field of medicine; development of software for the treatment, prevention, or diagnosis of cancer; Software as a service (SAAS) services, namely, hosting software for use by others for the treatment, prevention, or diagnosis of cancer; installation of computer software; software creation in the nature of computer software design; software engineering services; Design and writing of computer software; online provision of web-based applications, namely, providing temporary use of on-line non-downloadable applications for the treatment, prevention, and diagnosis of cancer; online provision of web-based software, namely, providing temporary use of online non-downloadable software for the treatment, prevention, or diagnosis of cancer; Consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 15, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 14, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 29, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
ASSIGNED TO LIE
Feb 18, 2025 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 13, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 13, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 13, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 13, 2025 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 13, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 11, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 27, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 27, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 27, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 27, 2025 CNEA
ASSIGNED TO EXAMINER
Jan 26, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2024 TROA
REFUSAL PROCESSED BY IB
May 1, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 6, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 6, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 2, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 28, 2023 REPR